Researchers find potential new target to treat malignant pleural mesothelioma
Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options. Despite advances in the treatment, the median survival remains 12 months from the time of diagnosis. Increased understanding ...
Jul 25, 2013
0
0